LILRB5 and neoplasm: Our findings provide a potential mechanistic explanation for this phenomenon: amyloid proteins activate LILRB2 and LILRB5 inhibitory receptors on myeloid cells, establishing an immunosuppressive TME that supports tumor growth and metastasis.